Good news for adults battling a specific type of blood cancer: on June 18, 2025, the FDA gave its stamp of approval to tafasitamab-cxix, known commercially as Monjuvi (Incyte/MorphoSys), to be ...

ProPublica spent 14 months investigating the FDA’s oversight of foreign drugmakers that send medications to the U.S. These ...

Each dose is about the size of a postage stamp and weighs less than an ounce ... does not anticipate any additional research before Anaphylm’s potential approval. “The FDA will engage with us, ask ...

Wildtype’s salmon is not the first lab-grown food to receive the FDA’s stamp of approval—that honor went to two companies’ cultured chicken in 2022—but this does mark the first time a ...

Kennedy said that removing all 17 members of the CDC's vaccine advisory panel was "necessary to reestablish public confidence ...

A Seattle infectious disease doctor, whose work was pivotal early in the COVID pandemic, shares more on her experience with ...

FDA updates CAR T-cell therapy labels for liso-cel and ide-cel, easing monitoring requirements and expanding access for ...

The FDA has approved its requested updated versions of expanded warning labels for COVID-19 vaccines. As Healio previously ...

Although Tissium first demonstrated its polymer material as a cardiovascular sealant, the application that the FDA just ...

The Food and Drug Administration (FDA) has approved Yeztugo (aka. lenacapavir or LEN), a twice-a-year injection that stops HIV from replicating inside cells, thereby reducing the risk of ...

Moderna has announced the FDA approval of a new, lower-dose messenger RNA (mRNA) vaccine against COVID-19, called mNEXSPIKE (mRNA-1283) (1).The product joins Moderna’s original COVID vaccine, Spikevax ...